Bv 418 ma body composition analyser

Blood pressure and heart rate were measured using the Omron HEM-70151T digital blood pressure monitor. Two measurements of each were taken and the mean was used in subsequent analysis. Weight was measured with the Tanita BV-418 MA body composition analyser. Height was measured using a Seca 202 height measure. Body mass index (BMI) was calculated as weight/height². Waist circumference at the level of the umbilicus was measured using a Wessex non-stretchable sprung tape measure. Baseline visual acuity was measured using a computerised semiautomated LogMAR system at 3 m, with best available correction.

Participants answered a detailed touch-screen questionnaire which included information regarding their age, gender, ethnicity, education, household income, history of disease and surgery, use of vitamin supplement (yes/no), as well as lifestyle factors, including sleep duration (hours/day), alcohol drinking (never/previous/current) and smoking status (never/former/current). Physical activity (PA) was assessed using the short form International Physical Activity Questionnaire [21 (link)], and the metabolic equivalent (MET)- minutes/week of PA was calculated based on their answers to time spent on walking, moderate PA and vigorous PA. Weight was measured with the BV-418 MA body composition analyser (Tanita), and height was measured in a barefoot standing position using a Seca 202 height measure. Body mass index was calculated based on measured weight (kg) divided by measured height (m) squared. Depression was recorded during the interview with a research nurse. Blood cholesterols, including triglycerides, high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), were measured by direct enzymatic methods ((Konelab, Thermo Fisher Scientific, Waltham, Massachusetts), and Glycosylated haemoglobin, Type A1C (HbA1c)) was measured using high-performance liquid chromatography on a Bio-Rad Variant II Turbo.